Mumps - Vaccination

Mumps is a viral infection that easily spreads through saliva and mucous. The MMR vaccine provides protection against this. Read on to know the right age of administering the vaccine and when to avoid it.

Mumps is a viral infection that easily spreads through saliva and mucous. Mumps is common only in those kids who have not received the vaccination. Mumps can affect any part of the body but it mainly affects the salivary glands (parotid glands). The glands swell when infected with the virus. 

Earlier this used to be very common but after the introduction of MMR (Measles, Mumps, rubella) vaccines, the cases have become rare.

Mumps – Signs and symptoms

Symptoms start appearing after 2 weeks of infection

Puffy cheeks, swollen jaws, and face

Fatigue, weakness

Fever

Headache

Loss of appetite

Mumps – Cause

Paramyxovirus causes mumps.

Mode of transmission

The virus transmits through saliva and mucus. It spreads by

1. Coughing, sneezing or talking

2. Sharing cups and utensils with others

3. Close contact (kissing)

4. Not washing hands properly and touching items that other people have touched

Mumps treatment

There is no treatment for mumps. Because antibiotics are ineffective on this virus. The virus needs to complete the course. You can only manage the condition with some doctor's prescribed suggestions. 

Apply cold or warm packs on swollen areas

Drink lots of liquid

Eat soft foods and take proper rest

Doctors may give OTC painkillers

Complications associated with mumps

Serious complications due to mumps are very rare. It would be good if you got it in your childhood days. Mumps in adulthood can have some possible problems.

1. Inflammation of ovaries, breast tissues in females. In males who have already gone through puberty, inflammation of testicles.

2. Encephalitis – Inflammation of the brain

3. Meningitis – Inflammation in the brain that covers the brain and spinal cord

4. Hearing loss

5. Cardiovascular problems

6. Pancreatitis

7. Miscarriage (if infection occurs during pregnancy)

Mumps prevention - MMR (Measles, Mumps, Rubella) vaccine

This is for active immunization against measles and rubella in infants, children, adolescents, and adults at risk.

Route of administration – Subcutaneous injection

Dose – The first dose of MMR is given to children – 12 months of age to 10 years of age

The second dose of MMR is given any time before the age of six years and thereafter measles and rubella vaccines are recommended.

Children who get this vaccine will be protected against the three diseases throughout their lives.

Minor side effects of MMR vaccine

Rash, fever, swollen cheeks, febrile seizures, and mild joint pain.

Avoid MMR vaccines in case

1. The child had a serious allergic reaction to an earlier dose of MMR vaccine.

2. The child had a medical condition that affects the immune system of the body

3. The child is taking steroids or other medicines that weaken the immune system

4. The child is undergoing chemotherapy or radiation therapy.

The introduction of MMR vaccines has resulted a decline in the incidence of measles, mumps, and rubella infections. However recent reports suggest that there is a re-emergence of mumps infection in the vaccinated population. The reason behind this re-emergence could be the poor efficacy of MMR vaccines. With the purpose of investigating mumps infection in the vaccinated and unvaccinated population, ICMR conducted the study in Chennai. In the study, it was found that the MMR vaccine failed to generate anti-mumps IgG. Low vaccine efficacy of the mumps component of the MMR vaccine was ruled out as the reason for this.

Disclaimer: The content on this site is for informational purposes only, and should not be taken as professional medical advice.  Always seek the guidance of your doctor or other health professionals for any questions you may have regarding your health or a medical condition.

 

 

 

Tags : #Health #Mumps #Mumpssymptoms #Mumpstreatment #Mumpscomplications #measles #Rubella #MMRvaccine #Viralinfection #Medicircle #SmitaKumar

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Transforming Brain Healthcare: India's Visionary Task Force for Neurological DisordersApril 25, 2024
The Battle Against Malaria: Rising Trends and Vaccine InnovationsApril 25, 2024
Talc and Asbestos Controversy: Inside Johnson & Johnson's Courtroom StruggleApril 25, 2024
The Hidden Struggles of Parenthood: Addressing Isolation, Loneliness, and BurnoutApril 25, 2024
FDA Confirms Bird Flu Virus Remnants in Pasteurized Milk: Safety and Regulatory InsightsApril 24, 2024
Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality April 23, 2024
Fateh Education announces partnership to expand educational opportunities for Indian studentsApril 23, 2024
10 Strategies to counter disinformation for the healthcare digital ecosystemApril 23, 2024
Is Selling Over-the-Counter (OTC) Drugs in General Stores A Step Towards Affordable Healthcare in IndiaApril 23, 2024
Student Health Crisis: Food Poisoning Incident Strikes Pune Coaching CentreApril 23, 2024
The Impact of Diabetes on Kidney Health: Diabetic Nephropathy ExplainedApril 23, 2024
Toddler Hospitalized After Consuming Expired Chocolates: Health Concerns RaisedApril 23, 2024
After months of diagnostic delay, a migrant worker could access TB services only when a community health worker met himApril 22, 2024
Indian Spices Contaminated with Cancer-Causing Chemical: Hong Kong Food Regulators Issue WarningApril 22, 2024
FTCCI organised a Workshop on Rooftop Kitchen GardeningApril 20, 2024
Children in Cities Exposed to Elevated Lead Levels: Study Reveals Urgent Health ConcernApril 20, 2024
Biocon Ventures into Weight-Loss Drug Market with Semaglutide DevelopmentApril 20, 2024
Innovative AI Assistance Empowers Moscow Doctors to Detect Cervical Spine Issues through MRI ScansApril 20, 2024
Air India Express ties up with AISATS for AeroWash Automated Aircraft Exterior Cleanings April 19, 2024
IndoSup raises strategic funding led by CCI group promoters Naresh Sharma and Satish Sharma; investors include Yatra.com’s Rohan Mittal April 19, 2024